KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intel (INTC) Change in Accured Expenses (2016 - 2025)

Intel (INTC) has 17 years of Change in Accured Expenses data on record, last reported at $247.0 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 115.42% year-over-year to $247.0 million; the TTM value through Dec 2025 reached $788.0 million, up 461.47%, while the annual FY2025 figure was $788.0 million, 461.47% up from the prior year.
  • Change in Accured Expenses reached $247.0 million in Q4 2025 per INTC's latest filing, up from -$481.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.4 billion in Q3 2024 and bottomed at -$1.9 billion in Q2 2022.
  • Average Change in Accured Expenses over 5 years is -$53.1 million, with a median of $157.0 million recorded in 2023.
  • The widest YoY moves for Change in Accured Expenses: up 1319.53% in 2024, down 387.61% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $531.0 million in 2021, then dropped by 28.63% to $379.0 million in 2022, then skyrocketed by 46.97% to $557.0 million in 2023, then plummeted by 387.61% to -$1.6 billion in 2024, then skyrocketed by 115.42% to $247.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $247.0 million in Q4 2025, -$481.0 million in Q3 2025, and $1.8 billion in Q2 2025.